isradipine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsac, C | 1 |
| Raymond, C | 1 |
| Martin-Moutot, N | 1 |
| Dargent, B | 1 |
| Couraud, F | 1 |
| Pouget, J | 1 |
| Seagar, M | 1 |
1 other study available for isradipine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Topics: Amyotrophic Lateral Sclerosis; Animals; Autoantibodies; Brain; Calcium Channel Blockers; Calcium Cha | 1996 |